In Silico-Identified Peptides of Five Borrelia burgdorferi Proteins Binding with High Affinity to Human Leukocyte Antigen (HLA) Class II Alleles
Biology · 28.03.2026 · 15 (7) · 547
DOI: 10.3390/biology15070547 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biology, online erschienen am 28.03.2026. Verfasst von Apostolos P Georgopoulos und 2 weiteren Autor:innen. Beteiligte Einrichtung: The HLA and Chronic Diseases Research Groups, Brain Sciences Center, Department of Veterans Affairs Health Care System, Minneapolis, MN 55417, USA. Die Arbeit nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Minnesota Foundation, U.S. Department of Veterans Affairs, University of Minnesota https://ror.org/017zqws13.
Abstract (Originalsprache)
To date, Lyme vaccine development has largely overlooked the vaccinee’s human leukocyte antigen (HLA) genetic makeup on which antibody production critically depends. Here, we evaluated in silico the predicted binding affinities of 192 HLA-II alleles with all 15-mer peptide sequences of five Borrelia burgdorferi proteins to identify peptides with strong binding affinity, as they would be the best candidates for antibody production in response to vaccination. We found the following: (a) 226 of the 1067 peptides tested (21.2%) were found to bind strongly to HLA-II molecules; (b) decorin-binding protein A had the greatest number of strongly binding peptides; and (c) 69 HLA-II alleles (primarily of the DRB1 gene) bound with strong affinity to peptides from Borrelia burgdorferi proteins. Finally, we tested for possible susceptibility to autoimmunity by any one of the 226 peptides above by searching for their occurrence in ~84,000 proteins of the human proteome and found overlap with only two 8-mer peptide sequences (embedded within the 226 15-mer peptides), neither of which was characterized by strong binding to HLA-I, suggesting a reduced likelihood of autoimmunity. These findings emphasize the importance of a personalized vaccine approach based on the vaccinee’s human leukocyte antigen genetic makeup and offer specific vaccine-candidate peptides that are predicted to maximize vaccine effectiveness and safety. The results of this computational study provide novel directions for future development of Lyme vaccines.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The HLA and Chronic Diseases Research Groups, Brain Sciences Center, Department of Veterans Affairs Health Care System, Minneapolis, MN 55417, USA.
- Department of Neuroscience, University of Minnesota Medical School, Minneapolis, MN 55455, USA.
- Institute for Health Informatics, University of Minnesota Medical School, Minneapolis, MN 55455, USA.
- Department of Psychiatry, University of Minnesota Medical School, Minneapolis, MN 55455, USA.
ORCID-Profile: Apostolos P Georgopoulos, Lisa M James
Förderung
- University of Minnesota Foundation
- U.S. Department of Veterans Affairs
- University of Minnesota https://ror.org/017zqws13
- U.S. Department of Veterans Affairs https://ror.org/05rsv9s98
Zitieren
APA
Georgopoulos, A. P., James, L. M., & Sanders, M. (2026). In Silico-Identified Peptides of Five Borrelia burgdorferi Proteins Binding with High Affinity to Human Leukocyte Antigen (HLA) Class II Alleles. Biology, 15(7), 547. https://doi.org/10.3390/biology15070547
Vancouver
Georgopoulos AP, James LM, Sanders M. In Silico-Identified Peptides of Five Borrelia burgdorferi Proteins Binding with High Affinity to Human Leukocyte Antigen (HLA) Class II Alleles. Biology. 2026;15(7):547. doi:10.3390/biology15070547
BibTeX
@article{Georgopoulos2026,
author = {Georgopoulos, Apostolos P and James, Lisa M and Sanders, Matthew},
title = {In Silico-Identified Peptides of Five Borrelia burgdorferi Proteins Binding with High Affinity to Human Leukocyte Antigen (HLA) Class II Alleles},
journal = {Biology},
year = {2026},
volume = {15},
number = {7},
pages = {547},
doi = {10.3390/biology15070547}
}
EUVIMED